Peter C. Keng

4.2k total citations
88 papers, 3.4k citations indexed

About

Peter C. Keng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peter C. Keng has authored 88 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 41 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Peter C. Keng's work include Cancer-related Molecular Pathways (16 papers), Cancer Cells and Metastasis (13 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Peter C. Keng is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Cancer Cells and Metastasis (13 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Peter C. Keng collaborates with scholars based in United States, China and Taiwan. Peter C. Keng's co-authors include Michael A. O’Reilly, Robert A. Bambara, Richard F. Borch, Christopher E. Helt, Donald Bodenner, Peter C. Dedon, Yuhchyau Chen, Soo Ok Lee, Dietmar W. Siemann and Rhonda J. Staversky and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Peter C. Keng

88 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Keng United States 35 1.7k 1.1k 595 510 418 88 3.4k
Peter G. Sacks United States 35 1.8k 1.1× 972 0.9× 545 0.9× 335 0.7× 320 0.8× 89 4.0k
Eugenio Erba Italy 39 2.1k 1.3× 1.3k 1.1× 785 1.3× 609 1.2× 529 1.3× 138 4.6k
Konstantin Christov United States 30 2.0k 1.2× 1.2k 1.1× 521 0.9× 265 0.5× 225 0.5× 100 3.7k
Guojun Wu China 38 2.5k 1.5× 1.2k 1.1× 761 1.3× 379 0.7× 336 0.8× 102 4.1k
Alberto Abbruzzese Italy 36 1.3k 0.8× 1.1k 1.0× 362 0.6× 433 0.8× 393 0.9× 82 3.3k
Jianping Gong China 29 2.1k 1.2× 1.0k 0.9× 598 1.0× 362 0.7× 460 1.1× 139 3.6k
Tracy Robson United Kingdom 40 1.8k 1.1× 638 0.6× 653 1.1× 424 0.8× 518 1.2× 116 3.8k
Sara Huerta‐Yépez Mexico 37 2.0k 1.2× 811 0.7× 791 1.3× 322 0.6× 736 1.8× 153 3.9k
Brian L. Hood United States 38 2.7k 1.6× 577 0.5× 576 1.0× 306 0.6× 389 0.9× 105 4.4k
Martin R. Johnson United States 38 2.2k 1.3× 2.3k 2.1× 542 0.9× 481 0.9× 241 0.6× 87 4.6k

Countries citing papers authored by Peter C. Keng

Since Specialization
Citations

This map shows the geographic impact of Peter C. Keng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Keng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Keng more than expected).

Fields of papers citing papers by Peter C. Keng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Keng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Keng. The network helps show where Peter C. Keng may publish in the future.

Co-authorship network of co-authors of Peter C. Keng

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Keng. A scholar is included among the top collaborators of Peter C. Keng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Keng. Peter C. Keng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaohong, Feng Chen, Yu Ren, et al.. (2019). IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2. Journal of Cancer Research and Clinical Oncology. 145(6). 1471–1484. 19 indexed citations
2.
Chen, Xiaohong, Feng Chen, Yu Ren, et al.. (2019). Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer. The Prostate. 79(12). 1414–1426. 14 indexed citations
3.
4.
5.
Zhang, Fuquan, Shanzhou Duan, Ying Tsai, et al.. (2016). Cisplatin treatment increases stemness through upregulation of hypoxia‐inducible factors by interleukin‐6 in non‐small cell lung cancer. Cancer Science. 107(6). 746–754. 50 indexed citations
6.
Chen, Yuhchyau, Irena Nowak, Jiaoti Huang, et al.. (2013). Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(1). 50–58. 20 indexed citations
7.
Zhang, Mei, Steven G Swarts, Liangjie Yin, et al.. (2011). Antioxidant Properties of Quercetin. Advances in experimental medicine and biology. 701. 283–289. 216 indexed citations
8.
Keng, Peter C., et al.. (2009). Transient Glutathione Depletion Determines Terminal Differentiation in HL‐60 Cells. Oxidative Medicine and Cellular Longevity. 3(1). 53–60. 17 indexed citations
9.
Zhang, Hong, Ollivier Hyrien, Kishan J. Pandya, Peter C. Keng, & Yuhchyau Chen. (2008). Tumor Response Kinetics after Schedule-Dependent Paclitaxel Chemoradiation Treatment for Inoperable Non-small Cell Lung Cancer: A Model for Low-Dose Chemotherapy Radiosensitization. Journal of Thoracic Oncology. 3(6). 563–568. 10 indexed citations
10.
Staversky, Rhonda J., Peter F. Vitiello, Sean C. Gehen, et al.. (2006). p21Cip1/Waf1/Sdi1 protects against hyperoxia by maintaining expression of Bcl-XL. Free Radical Biology and Medicine. 41(4). 601–609. 15 indexed citations
11.
Brandt, Patrick D., Christopher E. Helt, Peter C. Keng, & Robert A. Bambara. (2006). The Rad9 protein enhances survival and promotes DNA repair following exposure to ionizing radiation. Biochemical and Biophysical Research Communications. 347(1). 232–237. 14 indexed citations
12.
Chen, Miao‐Fen, et al.. (2005). Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer. 5(1). 158–158. 47 indexed citations
13.
Rancourt, Raymond C., Daniel Hayes, Patricia R. Chess, Peter C. Keng, & Michael A. O’Reilly. (2002). Growth arrest in G1 protects against oxygen‐induced DNA damage and cell death. Journal of Cellular Physiology. 193(1). 26–36. 55 indexed citations
14.
Tsai, M.A., Richard E. Waugh, & Peter C. Keng. (1998). Passive Mechanical Behavior of Human Neutrophils: Effects of Colchicine and Paclitaxel. Biophysical Journal. 74(6). 3282–3291. 68 indexed citations
15.
Liesveld, Jane L., Peter C. Keng, Jacob M. Rowe, John F. DiPersio, & Camille N. Abboud. (1994). Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines. Leukemia Research. 18(8). 609–616. 7 indexed citations
16.
Chapuis, Jean‐Charles, Peter C. Keng, & Dietmar W. Siemann. (1992). Activity off etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures. Anti-Cancer Drugs. 3(3). 245–252. 6 indexed citations
17.
Marraccino, Robert L., et al.. (1989). Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle. Biochemistry. 28(7). 2967–2974. 128 indexed citations
18.
West, Catharine, Peter C. Keng, & Robert M. Sutherland. (1988). Growth phase related variation in the radiation sensitivity of human colon adenocarcinoma cells. International Journal of Radiation Oncology*Biology*Physics. 14(6). 1213–1219. 16 indexed citations
19.
Marraccino, Robert L., Alan F. Wahl, Peter C. Keng, Edith M. Lord, & Robert A. Bambara. (1987). Cell cycle dependent activities of DNA polymerases .alpha. and .delta. in Chinese hamster ovary cells. Biochemistry. 26(24). 7864–7870. 22 indexed citations
20.
Chang, Alex Y. C. & Peter C. Keng. (1983). Inhibition of Cell Growth in Synchronous Human Hypernephroma Cells by Recombinant Interferon Alpha-D and Irradiation. Journal of Interferon Research. 3(4). 379–385. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter G. Sacks Breakdown of academic impact, for papers by Eugenio Erba Breakdown of academic impact, for papers by Konstantin Christov Breakdown of academic impact, for papers by Guojun Wu Breakdown of academic impact, for papers by Alberto Abbruzzese Breakdown of academic impact, for papers by Jianping Gong Breakdown of academic impact, for papers by Tracy Robson Breakdown of academic impact, for papers by Sara Huerta‐Yépez Breakdown of academic impact, for papers by Brian L. Hood Breakdown of academic impact, for papers by Martin R. Johnson
Rankless by CCL
2026